AlpENa Biosciences Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

AlpENa Biosciences General Information

Description

Developer of bispecific antibodies designed to activate immune cells to target and destroy tumor cells as cancer therapeutics. The company is currently operating in Stealth Mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Aeschenvorstadt 36
  • 4051 Basel
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Corporate Office
  • Aeschenvorstadt 36
  • 4051 Basel
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AlpENa Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Dec-2024 Completed Stealth
To view AlpENa Biosciences’s complete valuation and funding history, request access »

AlpENa Biosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amsterdam Academic Ventures Venture Capital Minority
Amsterdam UMC Ventures Holding Venture Capital Minority
Versant Ventures Venture Capital Minority
To view AlpENa Biosciences’s complete investors history, request access »

AlpENa Biosciences FAQs

  • When was AlpENa Biosciences founded?

    AlpENa Biosciences was founded in 2023.

  • Where is AlpENa Biosciences headquartered?

    AlpENa Biosciences is headquartered in Basel, Switzerland.

  • What industry is AlpENa Biosciences in?

    AlpENa Biosciences’s primary industry is Biotechnology.

  • Is AlpENa Biosciences a private or public company?

    AlpENa Biosciences is a Private company.

  • What is AlpENa Biosciences’s current revenue?

    The current revenue for AlpENa Biosciences is .

  • Who are AlpENa Biosciences’s investors?

    Amsterdam Academic Ventures, Amsterdam UMC Ventures Holding, and Versant Ventures have invested in AlpENa Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process